Found: 12
Select item for more details and to access through your institution.
Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 9, p. 1228, doi. 10.3390/cells12091228
- By:
- Publication type:
- Article
COVID-19: Diabetes Perspective—Pathophysiology and Management.
- Published in:
- Pathogens, 2023, v. 12, n. 2, p. 184, doi. 10.3390/pathogens12020184
- By:
- Publication type:
- Article
An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101639
- By:
- Publication type:
- Article
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness.
- Published in:
- Vaccines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/vaccines10101751
- By:
- Publication type:
- Article
Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32905-w
- By:
- Publication type:
- Article
Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071125
- By:
- Publication type:
- Article
Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060841
- By:
- Publication type:
- Article
Clinical, Epidemiological and Experimental Approaches to Assess Adverse Health Outcomes of Indoor Biomass Smoke Exposure: Conclusions from An Indo-Swedish Workshop in Mysuru, January 2020.
- Published in:
- Toxics, 2020, v. 8, n. 3, p. 68, doi. 10.3390/toxics8030068
- By:
- Publication type:
- Article
Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 9, p. 1, doi. 10.1371/journal.ppat.1006628
- By:
- Publication type:
- Article
Induction of KSHV latency-associated nuclear antigen (LANA) by hypoxia and hypoxia-inducible factors (HIF).
- Published in:
- Infectious Agents & Cancer, 2012, v. 7, n. Suppl 1, p. 1, doi. 10.1186/1750-9378-7-S1-P37
- By:
- Publication type:
- Article
Induction of KSHV latency-associated nuclear antigen (LANA) by hypoxia and hypoxia-inducible factors (HIF)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Characterization of the Activation of Protein Tyrosine Phosphatase, Receptor-Type, Z Polypeptide 1 (PTPRZ1) by Hypoxia Inducible Factor-2 Alpha.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009641
- By:
- Publication type:
- Article